How Samsung Bioepis Is Laying A Path For Ophthalmic Biosimilars

Strategy Head Josh Lee Also Emphasizes Need For Biosimilar Education And Incentives

 
• By Dave Wallace
  
Josh Lee, Samsung Bioepis
Josh Lee talks about how Samsung Bioepis is preparing to break into the ophthalmology market • Source: Samsung Bioepis

More from Biosimilars

More from Products